AU2002338849A1 - Pharmaceutical composition for the treatment of disorders of non-human mammals - Google Patents

Pharmaceutical composition for the treatment of disorders of non-human mammals

Info

Publication number
AU2002338849A1
AU2002338849A1 AU2002338849A AU2002338849A AU2002338849A1 AU 2002338849 A1 AU2002338849 A1 AU 2002338849A1 AU 2002338849 A AU2002338849 A AU 2002338849A AU 2002338849 A AU2002338849 A AU 2002338849A AU 2002338849 A1 AU2002338849 A1 AU 2002338849A1
Authority
AU
Australia
Prior art keywords
disorders
treatment
pharmaceutical composition
human mammals
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002338849A
Inventor
Peter Bette
Iris Brandstetter
Frank Hilberg
Rainer Kleemann
Jacobus Van Meel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2002338849A1 publication Critical patent/AU2002338849A1/en
Abandoned legal-status Critical Current

Links

AU2002338849A 2001-10-03 2002-10-01 Pharmaceutical composition for the treatment of disorders of non-human mammals Abandoned AU2002338849A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01123700.5 2001-10-03

Publications (1)

Publication Number Publication Date
AU2002338849A1 true AU2002338849A1 (en) 2003-04-22

Family

ID=

Similar Documents

Publication Publication Date Title
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
ZA200401004B (en) Combination for the treatment of inflammatory disorders
IL209842A0 (en) Compounds for the treatment of metabolic disorders
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
GB2349570B (en) Compositions for treatment of disorders of the oesophagus associated with reflux
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
AU2003286728A1 (en) Compounds for the treatment of metabolic disorders
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2002338849A1 (en) Pharmaceutical composition for the treatment of disorders of non-human mammals
AU2003239967A1 (en) Compound for the treatment of cns disorders
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2002365863A1 (en) The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU7445601A (en) Pharmaceutical composition for the treatment of multiple sclerosis
AU2002334310A1 (en) 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
AUPR637001A0 (en) Pharmaceutical composition for the treatment of skin conditions
AU2002304579A1 (en) Oral compositions for the treatment of obese, non-diabetic mammals, including humans
SI1503747T1 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders